An idea borrowed from nature is the basis for a breakthrough therapy that partially restored vision to a blind man. The therapy uses light-sensing proteins found in bioluminescent algae.
In a paper published in May in Nature Medicine, an international team of scientists reported on this first case of partial vision recovery employing tools of a technology called optogenetics. The study marks the first time a patient has achieved functional recovery in any neurodegenerative disease with optogenetics.